Inquiry Basket
Aaf-Arg-OH HCl, a substrate of carboxypeptidase B-type enzymes, has been used to determine the activation of TAFI (thrombin activatable fibrinolysis inhibitor, carboxypeptidase U) by thrombin and thrombin-thrombomodulin.
Aaf-Arg-OH HCl, also recognized as Acetylarginylhydroxamic Acid Hydrochloride, serves as a fundamental biochemical reagent with diverse applications in scientific and medical domains. Here are the key applications:
Protease Inhibition Studies: Aaf-Arg-OH HCl emerges as a potent inhibitor targeting serine proteases in the realm of biochemical research. By binding intricately to the active sites of these proteases, it effectively halts the catalysis of peptide bonds, paving the way for in-depth explorations into enzyme kinetics and inhibition mechanisms. This critical exploration is instrumental in the quest for developing therapeutic avenues tailored to combat protease-associated maladies, including cancers and inflammatory conditions.
Enzyme Assay Development: Delving into the realm of enzyme assay development, Aaf-Arg-OH HCl assumes a pivotal role in calibrating and standardizing protease activity measurements. Its inhibitory prowess serves as a stringent control mechanism, ensuring the precision and sensitivity of enzyme assays. This meticulous calibration guarantees the generation of accurate and reproducible results, enhancing the reliability of research findings in both investigative and diagnostic settings.
Pharmaceutical Research: Positioned as a crucial asset in the initial phases of drug discovery, Aaf-Arg-OH HCl aids researchers in the screening and characterization of potential protease inhibitors. Its robust inhibition profile offers valuable insights, aiding in the identification of promising drug candidates for a myriad of ailments. Unraveling its intricate interplay with proteases empowers scientists to craft more potent and selective inhibitors, pushing the boundaries of pharmaceutical innovation.
Biotechnology Applications: Within the dynamic realm of biotechnology, Aaf-Arg-OH HCl finds extensive utility in unraveling the intricacies of protein degradation pathways. By selectively inhibiting specific proteases, researchers embark on a journey to illuminate the roles of these enzymes in the realms of protein turnover and stability. This knowledge proves invaluable in optimizing production processes for proteins and enhancing the quality benchmarks for biopharmaceuticals, fueling advancements in biotechnological frontiers.
